Thrixen co-founder and CEO Shavit Clein
Singapore-based startup Thrixen, which develops a diagnostics platform for infectious diseases, has secured funding, its co-founder and CEO Shavit Clein announced in a LinkedIn post.
The investors are 22Health Ventures, an early-stage healthtech investment firm and biotech company Aldevron’s co-founder John Ballantyne.
The development was first reported by The Business Times, which pegged the funding amount at US$7 million. The capital will be used to advance the development of its diagnostic technology platform.
Also Read: Why ClavystBio believes in life science as a key driver of Singapore’s economy in the future
“I am thrilled to announce that our Thrixen has secured new investors who share our vision for the future of diagnostics! We are honoured that they have put their trust in our team and technology,” Shavit Clein’s post said.
“We have been working closely with the amazing team at 22Health Ventures, who are true partners in our journey to improve healthcare outcomes for patients all over the world. With John Ballantyne , whose support and guidance have been invaluable, we have an incredible team to help us achieve our vision for Thrixen,” he added.
Thrixen was founded in 2021 by international scientists from Singapore and the US. It is a biotech/medtech company that develops a rapid diagnostic platform for infectious diseases. It offers systems for neutralising antibody tests for the detection of COVID-19 diseases.
The startup is involved in the R&D of diagnostic systems and has proprietary technology for biomarker detection, multiplexing, rapid diagnostic testing, and protein engineering.
—
X marks Echelon. Join us at Singapore EXPO on May 15-16 for the 10th edition of Asia’s leading tech and startup conference. Enjoy 2 days of building connections with potential investors, partners, and customers, exploring innovation, and sharing insights with 8,000+ key decision-makers of Asia’s tech ecosystem. Get your tickets here.
Want more from your Echelon experience? Be an Echelon X sponsor or exhibitor. Send enquiry here.
The post Thrixen bags US$7M in funding to advance its diagnostics platform appeared first on e27.